On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …
Tag Archive: multidrug resistance
Mar 28
SFB 2026 in Atlanta: An Invited 30-Minute Talk on Antibiofilm Coatings, a Wound-Healing Poster, and an Oral Presentation from the Lab
The Society For Biomaterials (SFB) 2026 Annual Meeting & Exposition brought our lab to the Hyatt Regency Atlanta from March 25–28, 2026, and it was one of the most rewarding conferences for us this year. The lab had three contributions spanning our antibiofilm-coating, antimicrobial drug-delivery, and cancer-theranostic programs, and I was particularly honored to be …
Aug 30
Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL)
Dr. Nallathamby presented on his abiotic biomimicking antibacterial Nanoparticles, and how they were successfully tested against A. baumannii BA1605 S.aureus USA300, P.aeruginosa FRD1, K. pneumoniae, C.striatum, E. faecalis, and S. pyogenes. We saw little to no evolution of resistance at doses above the MIC. Additionally, we observed what looks like inflammation-free wound healing in mouse and rat models. The wound size stabilizes as soon as the formulation is …
Aug 21
Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa
Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079
May 24
MTEC Annual meeting in Baltimore MD (May 24, 2024)
Really useful information on working with the DoD’s medical enterprise. MTEC annual meeting in Baltimore, MD. Phage Mimicking antibacterial nanoparticles was a hit. New Partnering opportunity on the horizon. Exciting times ahead! #GOIRISH #MTEC #AMR #NEXTGEN #ANTIBIOTICS
May 07
Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024
Notre Dame senior Kevin Armknecht, affiliated with the Berthiaume Institute for Precision Health, has earned the Best Publication Imaging Award from ND’s Integrated Imaging Facility (NDIIF) for images he contributed to a recent Nanoscale Advances publication. Armknecht, who is majoring in pre-professional studies with minors in compassionate care in medicine and poverty studies, produced these …
Mar 01
Congratulations to Argerie Guevara (NURF 2021) on being a First Author in our Upcoming Publication in Military Medicine | Oxford Academic
Our manuscript titled, “PLGA nanoparticles formulations loaded with antibiotics induce sustained and controlled antibiotics release for prolonged antibacterial action against MRSA, and Pseudomonas aeruginosa FRD1” (MILMED-D-23-00750R1), has been accepted for publication. This is the first time we are publishing in the supplement to the Military Health Sciences Research Symposium. The manuscript was based on our …
Nov 16
Nallathamby Lab is one of 20 Participants Invited to Present Phage-Mimicking Antibacterial Nanoparticle Prototype at the Inaugural Joint Innovation Medical Symposium (JIMS) at Pope Army Airfield/Fort Bragg (Nov 16-17, 2022)
In recent combat theaters, despite advances in treating critical injuries leading to higher survival rates, there has been an increase in the number of infections linked to trauma, particularly those caused by bacteria resistant to multiple drugs 1,2. Research from the Trauma Infectious Disease Outcomes Study indicates that 27% of those evacuated with injuries develop …
May 14
Nallathamby Lab Presents Novel Antibacterial and Novel Chemotherapeutics Work at MRS 2022 Spring Meeting (May 8-13, 2022| Honolulu, Hawai’i)
Our research looks at the basic mechanism of drug resistance in bacteria or cancer cells and then we work on translational solutions to combat these problems. Our approach felt validated at this meeting where we networked with industry end-users as well as disease-on-a chip modeling academicians.
NIH Funding Opportunities
- Request for Information (RFI): Opportunities to Reduce Administrative Burden in NIH Extramural Research October 8, 2026Notice NOT-OD-26-118 from the NIH Guide for Grants and Contracts
- Notice to rescind NOT-MH-06-108, "Notice to Announce Availability of Biomaterials, Phenotyping Information, and Genotyping Data from the NIMH Genetics Initiative for Whole Genome Association Studies" October 8, 2026Notice NOT-MH-26-080 from the NIH Guide for Grants and Contracts
- Request for Information (RFI): Strategies to Advance RAPIDs and Real-World Evidence for Serious Mental Illnesses and Related Brain Disorders October 8, 2026Notice NOT-MH-26-090 from the NIH Guide for Grants and Contracts
- Notice of Informational Webinar for RFA-AI-27-018, Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) October 7, 2026Notice NOT-AI-26-004 from the NIH Guide for Grants and Contracts
- Request for Information: Timing of Submission of Prior Approval Requests for IDeA Program Post-Award Projects October 5, 2026Notice NOT-GM-26-012 from the NIH Guide for Grants and Contracts
- Accelerated Implementation of Data Management and Sharing Plan Changes for NIH Career Development (K) Awards October 5, 2026Notice NOT-OD-26-120 from the NIH Guide for Grants and Contracts
Recent Comments